LGI1 and hereditary elliptocytosis: The highly variable interval in “first symptoms to immunosuppressive treatment” may be explained by the increasing awareness for NMDAR and LGI1 encephalities, whereas diagnosis might be challenging for HE/SREAT, or antibodies testing for IGLON5 or GAD-67 was not available until recently.